将2017年修订版McDonald多发性硬化诊断标准应用于典型临床孤立综合征患者
该前瞻性临床孤立综合征(CIS)队列纳入229例患者,评估2017版与2010版McDonald标准预测临床确诊多发性硬化(CDMS)的准确性。2017版标准敏感性更高(68% vs 36%),但特异性更低(61% vs 85%),基线时更多患者可诊断为多发性硬化(54% vs 26%)。
要点
- 2017版McDonald标准较2010版敏感性更高(68% vs 36%),但特异性更低(61% vs 85%)。
- 2017版标准在基线时诊断多发性硬化的比例更高(54% vs 26%)。
- 2017版标准使更多病程不活跃的患者被诊断为多发性硬化。
核心结论
- 2017年修订版McDonald标准与2010版标准相比,对第二次发作的敏感性更高但特异性更低。
- 其代价是使更多病程不活跃的患者被诊断为多发性硬化。
研究设计与样本
- 前瞻性CIS队列研究,纳入229例来自荷兰鹿特丹Erasmus MC及多家地区医院、于2006年3月至2016年8月间入组的患者。
- 患者在症状出现后3个月内接受基线磁共振成像扫描,必要时行腰椎穿刺。
- 数据分析于2017年12月至2018年1月进行。
主要发现
- 229例CIS患者中,女性167例(73%),平均(标准差)年龄为33.5(8.2)岁。
- 在平均(标准差)65.3(30.9)个月的随访期间,113例患者(49%)被诊断为CDMS。
- 2017版标准敏感性高于2010版(68%;95%CI,57%-77% vs 36%;95%CI,27%-47%;P < .001)。
- 2017版标准特异性低于2010版(61%;95%CI,50%-71% vs 85%;95%CI,76%-92%;P < .001)。
- 使用2017版标准,基线时可作出更多多发性硬化诊断(n = 97 [54%];95%CI,47%-61% vs n = 46 [26%];95%CI,20%-32%;P < .001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: In 2017, the International Panel on Diagnosis of Multiple Sclerosis revised the McDonald 2010 criteria for the diagnosis of multiple sclerosis (MS). The new criteria are easier to apply and could lead to more and earlier diagnoses. It is important to validate these criteria globally for their accuracy in clinical practice. OBJECTIVE: To evaluate the diagnostic accuracy of the 2017 criteria vs the 2010 criteria in prediction of clinically definite MS in patients with a typical clinically isolated syndrome (CIS). DESIGN, SETTING AND PATIENTS: A total of 251 patients at Erasmus MC, Rotterdam, the Netherlands, in collaboration with several regional hospitals, fulfilled the inclusion criteria. Thirteen patients received another diagnosis early in the diagnostic process and therefore were excluded from the analyses. Nine patients with CIS declined to participate in the study. This left 229 patients who were included between March 2006 and August 2016 in this prospective CIS cohort. Patients underwent a baseline magnetic resonance imaging scan within 3 months after onset of symptoms and, if clinically required, a lumbar puncture was performed. Data were analyzed between December 2017 and January 2018. MAIN OUTCOMES AND MEASURES: Sensitivity, specificity, accuracy, and positive and negative predictive value were calculated after 1, 3, and 5 years for the 2017 vs the 2010 criteria. RESULTS: Among the 229 patients with CIS, 167 were women (73%), and the mean (SD) age was 33.5 (8.2) years. One hundred thirteen patients (49%) were diagnosed as having CDMS during a mean (SD) follow-up time of 65.3 (30.9) months. Sensitivity for the 2017 criteria was higher than for the 2010 criteria (68%; 95% CI, 57%-77% vs 36%; 95% CI, 27%-47%; P < .001), but specificity was lower (61%; 95% CI, 50%-71% vs 85%; 95% CI, 76%-92%; P < .001). Using the 2017 criteria, more MS diagnoses could be made at baseline (n = 97 [54%]; 95% CI, 47%-61% vs n = 46 [26%]; 95% CI, 20%-32%; P < .001). In the group with at least 5 years of follow-up, 33% of patients who were diagnosed as having MS using the 2017 criteria did not experience a second attack during follow-up vs 23% when using the 2010 criteria. CONCLUSIONS AND RELEVANCE: The 2017 revised McDonald criteria are associated with greater sensitivity but less specificity for a second attack than the previous 2010 criteria. The tradeoff is that it leads to a higher number of MS diagnoses in patients with a less active disease course.
引用
- van der Vuurst de Vries RM, Mescheriakova JY, Wong YYM, et al. Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients With a Typical Clinically Isolated Syndrome. JAMA Neurol. 2018. PMID: 30083703. doi:10.1001/jamaneurol.2018.2160
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。